PetMed Express
PETS
166 hedge funds and large institutions have $281M invested in PetMed Express in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 59 reducing their positions, and 22 closing their positions.
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
2% more funds holding
Funds holding: 163 → 166 (+3)
1.69% more ownership
Funds ownership: 79.3% → 80.99% (+1.7%)
2% less capital invested
Capital invested by funds: $286M → $281M (-$4.96M)
12% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 59
28% less call options, than puts
Call options by funds: $5.12M | Put options by funds: $7.07M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$4.27M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.72M |
| 3 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$2.1M |
| 4 |
CCM
Chimera Capital Management
New York
|
+$1.84M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.56M |
Top Sellers
PETS Hedge Fund Activity: Q1 2023 in Review
166 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in PetMed Express (PETS) for Q1 2023, worth a combined $281M — down 1.7% from $286M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new PETS positions and 22 closed out — a net gain of 5 holders — while 52 added to existing stakes and 59 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $4.27M. The largest seller was Charles Schwab, cutting an estimated $5.8M.
- 166 institutional investors held PetMed Express (PETS) as of Q1 2023, up from 163 in Q4 2022.
- Funds reported $281M of PetMed Express stock for Q1 2023, down 1.7% quarter-over-quarter.
- 27 funds opened new PetMed Express positions in Q1 2023 and 22 closed out, a net change of +5 holders.
- The largest PetMed Express buyer in Q1 2023 was Citadel Advisors, an estimated $4.27M added.
- The largest PetMed Express seller in Q1 2023 was Charles Schwab, an estimated $5.8M sold.
Based on aggregated 13F filings for Q1 2023.